Kimberly Barron
Foot & Ankle Surgery · San Antonio, TXNPI 1124475926
Payments from drug & device makers
Across 33 payments — averaging $201.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$3K
- CDC Medical LLC$2K
- Stryker$737
- Smith+Nephew$270
- Access Pro Medical, LLC$255
- Treace Medical Concepts, Inc.$154
- plus $709 from 7 others
What the payments were for
- Speaking & faculty fees$1,60024%
- Food & beverage$2,94844%
- Education$2,10932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 7 | $2,521 |
| CDC Medical LLC | 2 | $2,010 |
| Stryker | 8 | $737 |
| Smith+Nephew | 3 | $270 |
| Access Pro Medical, LLC | 2 | $255 |
| Treace Medical Concepts, Inc. | 3 | $154 |
| Johnson & Johnson | 1 | $147 |
| Alafair Biosciences, Inc. | 1 | $142 |
| Vertex | 1 | $125 |
| Amgen | 1 | $110 |
| Carbofix Orthopedics Inc | 1 | $105 |
| Bioventus LLC | 2 | $65 |
| Mission Medical Distribution, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$7,581
- Kerecis GraftGuide$1,895
- Kerecis Omega3 Marigen$1,417
- Kerecis Omega3 SurgiClose$354
- RAYOS$331
- VARIAX$268
- Matriderm$255
- Taylor Spatial Frame$241
- Kerecis Omega3 Wound$173
- N/A$160
- MOTOBAND$147
- VersaWrap$142
- JOURNAVX$125
- Lapiplasty System$121
How this compares
$6,657 in reported general payments places this provider in the 60th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $469 |
| Ammonium Lactate | 23 | $357 |
| Diclofenac Sodium | 18 | $199 |
| Terbinafine Hcl | 17 | $148 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in San Antonio
- Richard PollakSan Antonio$6.1M
- Chad HowzeSan Antonio$2.4M
- Ian BarronSan Antonio$162K
- Walter StrashSan Antonio$86K
- Thomas ZgonisSan Antonio$79K
- Joseph CaporussoMcAllen$6M
- Mark DaltonAustin$4.1M
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.